140 related articles for article (PubMed ID: 27613576)
21. Genomic research advances pancreatic cancer's early detection and treatment.
Brower V
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142448
[No Abstract] [Full Text] [Related]
22. Familial pancreatic cancer: a review.
Lynch HT; Smyrk T; Kern SE; Hruban RH; Lightdale CJ; Lemon SJ; Lynch JF; Fusaro LR; Fusaro RM; Ghadirian P
Semin Oncol; 1996 Apr; 23(2):251-75. PubMed ID: 8623061
[TBL] [Abstract][Full Text] [Related]
23. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
24. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
Zhu AX; Clark JW; Willett CG
Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
[TBL] [Abstract][Full Text] [Related]
25. Medical Management of Pancreatic Neuroendocrine Tumors: Current and Future Therapy.
Chan JA; Kulke MH
Surg Oncol Clin N Am; 2016 Apr; 25(2):423-37. PubMed ID: 27013373
[TBL] [Abstract][Full Text] [Related]
26. [Curative surgical treatment of inoperable pancreatic cancer after neoadjuvant therapy].
Arkosy P; Sasi SL; Enyedi A; Szántó J; András C; Sápy P
Magy Seb; 2005 Feb; 58(1):29-33. PubMed ID: 16018598
[TBL] [Abstract][Full Text] [Related]
27. Early detection of pancreatic cancer: a possibility in some cases but not a reality in most.
Goh KL; Yoon BK
J Dig Dis; 2012 Aug; 13(8):389-92. PubMed ID: 22788923
[TBL] [Abstract][Full Text] [Related]
28. The need for effective pancreatic cancer detection and management: a biomarker-based strategy.
Crawley AS; O'Kennedy RJ
Expert Rev Mol Diagn; 2015; 15(10):1339-53. PubMed ID: 26394703
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant treatments for resectable pancreatic cancer.
Ueno H; Kosuge T
J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
[TBL] [Abstract][Full Text] [Related]
30. Advancements in the management of pancreatic cancer: 2013.
Saif MW
JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
[TBL] [Abstract][Full Text] [Related]
31. Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
Backman S; Norlén O; Eriksson B; Skogseid B; Stålberg P; Crona J
Anticancer Res; 2017 Feb; 37(2):705-712. PubMed ID: 28179320
[TBL] [Abstract][Full Text] [Related]
32. Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma.
Du L; DeFoe M; Ruzinova MB; Olsen JR; Wang-Gillam A
Hematol Oncol Clin North Am; 2015 Aug; 29(4):717-26. PubMed ID: 26226906
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant therapy for resectable pancreatic adenocarcinoma: review of the current treatment approaches and future directions.
Antoniou G; Kountourakis P; Papadimitriou K; Vassiliou V; Papamichael D
Cancer Treat Rev; 2014 Feb; 40(1):78-85. PubMed ID: 23810287
[TBL] [Abstract][Full Text] [Related]
34. Molecular markers of early pancreatic cancer.
Goggins M
J Clin Oncol; 2005 Jul; 23(20):4524-31. PubMed ID: 16002843
[TBL] [Abstract][Full Text] [Related]
35. Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.
Shaib WL; Ip A; Cardona K; Alese OB; Maithel SK; Kooby D; Landry J; El-Rayes BF
Oncologist; 2016 Feb; 21(2):178-87. PubMed ID: 26834159
[TBL] [Abstract][Full Text] [Related]
36. Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.
Mosquera C; Maglic D; Zervos EE
Cancer Genet; 2016 Dec; 209(12):567-581. PubMed ID: 27613577
[TBL] [Abstract][Full Text] [Related]
37. Role of chemoradiotherapy in the adjuvant and neoadjuvant settings for resectable pancreatic cancer.
Sen N; Falk S; Abrams RA
Clin Oncol (R Coll Radiol); 2014 Sep; 26(9):551-9. PubMed ID: 25024090
[TBL] [Abstract][Full Text] [Related]
38. Short term chemotherapy followed by radiofrequency ablation in stage III pancreatic cancer: results from a single center.
Frigerio I; Girelli R; Giardino A; Regi P; Salvia R; Bassi C
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):574-7. PubMed ID: 23591744
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors.
Ananda G; Mockus S; Lundquist M; Spotlow V; Simons A; Mitchell T; Stafford G; Philip V; Stearns T; Srivastava A; Barter M; Rowe L; Malcolm J; Bult C; Karuturi RK; Rasmussen K; Hinerfeld D
Exp Mol Pathol; 2015 Feb; 98(1):106-12. PubMed ID: 25562415
[TBL] [Abstract][Full Text] [Related]
40. Evolving 'omics' technologies for diagnostics of head and neck cancer.
Nagaraj NS
Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
